Compound used to control cholesterol may also kill breast cancer
February 23rd, 2011 - 3:07 pm ICT by ANIWashington, Feb 23 (ANI): A new University of Missouri study has found that a compound used to control cholesterol may also kill breast cancer cells.
Salman Hyder, the Zalk Endowed Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center, and his research team discovered that a small molecule, Ro 48-8071, initially developed for controlling cholesterol synthesis ‘dramatically destroys’ human breast cancer cells.
This development was discovered as Hyder’s research team was investigating PRIMA-1, a drug that targets a common mutated gene in human breast cancer cells, and kills tumor cells.
During the course of the study, Xiaoquin Zou, of the MU Department of Physics and Astronomy, compared the chemistry of PRIMA-1 binding to thousands of proteins using a software program she developed called MDock.
Hyder and Zou found that PRIMA-1 showed excellent binding properties to a protein called oxidosqualene cyclase, (OSC) that is known to be important for producing cholesterol.
This led Hyder’s team to investigate whether known OSC inhibitors, such as Ro 48-8071, developed to stop cholesterol production, also killed breast cancer cells.
“We had been working with PRIMA-1 for some time, and what we didn’t quite understand is exactly how it killed tumor cells. With the current findings, we think it’s possible that one mechanism utilized by PRIMA-1 to kill cancer cells may include shutting down cholesterol synthesis, but we still don’t know for certain if that’s the case. What we do know is that Ro 48-8071 does stop cholesterol synthesis, and it proved to be just as effective in destroying cancer cells as PRIMA-1, without harming other normal breast cells, which is a big advantage,” said Hyder.
The findings have been published in the Journal of Molecular Graphics and Modelling. (ANI)
- Parsley could help in breast cancer treatment - May 10, 2011
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Cholesterol shows promise in fighting cancer - Apr 23, 2012
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- New drug shrinks cancer, with few side effects - Apr 07, 2011
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Protein discovery could lead to better autoimmune disease, cancer drugs - Mar 03, 2011
- Protein that fuels inflammation in pancreatic and breast tumors identified - Feb 22, 2011
- Motor protein that blocks ovarian tumor growth found - Apr 27, 2011
- New potential target for breast cancer therapy identified - Dec 23, 2010
- Western diet linked to increased risk of breast cancer - Jan 07, 2011
- Protein that makes tumor cells in breast cancer resistant to treatments - Dec 15, 2010
- Key culprit in breast cancer metastasis identified - Feb 17, 2011
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
Tags: binding properties, biomedical sciences, breast cancer, breast cancer cells, breast cells, cardiovascular research center, cholesterol, cholesterol production, cholesterol synthesis, college of veterinary medicine, dalton, department of physics, human breast cancer, missouri study, molecular graphics, osc, software program, tumor angiogenesis, tumor cells, university of missouri